Displaying drugs 15201 - 15225 of 15534 in total
SGN-1
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Alidornase alfa
Investigational
Eneboparatide
Investigational
Haptoglobulin 1/1 (Plasma Derived)
Investigational
KB407
Investigational
Belcesiran
Investigational
SPK-7001
Investigational
M012
Investigational
Nadunolimab
Investigational
OAV401
Investigational
ET-101
Investigational
MRT5005
MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational
BVX-20
Investigational
OBI-888
Investigational
4A10
Investigational
M002
Investigational
NCATS-BL0746
Investigational
AMG-553
AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector.
Investigational
TCB-008
TCB-008 is an Allogeneic CD3+ T lymphocyte ex vivo expanded expressing the gamma delta T-cell receptor.
Investigational
Riliprubart
Investigational
EO-3021
Investigational
SMART101
SMART101 is an investigational cell therapy comprising human allogeneic CD34-CD7+ T cell progenitors that were cultured ex vivo.
Investigational
Displaying drugs 15201 - 15225 of 15534 in total